Masimo Co. (NASDAQ:MASI) was the recipient of a significant decline in short interest in the month of January. As of January 12th, there was short interest totalling 876,332 shares, a decline of 26.3% from the December 29th total of 1,189,834 shares. Based on an average trading volume of 463,935 shares, the short-interest ratio is presently 1.9 days. Currently, 1.8% of the shares of the company are sold short.
In related news, EVP Yongsam Lee sold 5,000 shares of the business’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $89.89, for a total transaction of $449,450.00. Following the transaction, the executive vice president now directly owns 74,000 shares in the company, valued at $6,651,860. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Steven Barker sold 10,000 shares of the business’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $90.00, for a total value of $900,000.00. Following the transaction, the director now owns 73,249 shares in the company, valued at $6,592,410. The disclosure for this sale can be found here. Insiders have sold 65,074 shares of company stock worth $5,798,945 over the last 90 days. Corporate insiders own 16.60% of the company’s stock.
Several hedge funds have recently added to or reduced their stakes in the company. DekaBank Deutsche Girozentrale grew its position in Masimo by 78.3% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 2,106 shares of the medical equipment provider’s stock worth $182,000 after acquiring an additional 925 shares during the last quarter. Advisor Group Inc. grew its position in Masimo by 38.4% during the 2nd quarter. Advisor Group Inc. now owns 2,361 shares of the medical equipment provider’s stock worth $216,000 after acquiring an additional 655 shares during the last quarter. Intellectus Partners LLC bought a new stake in Masimo during the 2nd quarter worth approximately $237,000. Shelton Capital Management bought a new stake in Masimo during the 2nd quarter worth approximately $269,000. Finally, Jane Street Group LLC bought a new stake in Masimo during the 3rd quarter worth approximately $317,000. Institutional investors own 83.64% of the company’s stock.
Shares of Masimo (MASI) opened at $91.54 on Monday. Masimo has a 12 month low of $71.15 and a 12 month high of $104.71. The firm has a market capitalization of $4,730.00, a P/E ratio of 14.51, a PEG ratio of 3.49 and a beta of 0.72.
Masimo (NASDAQ:MASI) last released its quarterly earnings data on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.17. Masimo had a return on equity of 22.17% and a net margin of 45.83%. The company had revenue of $193.69 million for the quarter, compared to analyst estimates of $189.01 million. During the same period in the prior year, the company posted $0.52 EPS. The company’s revenue was up 15.6% compared to the same quarter last year. equities analysts expect that Masimo will post 2.95 EPS for the current year.
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.